Fluid-Screen
Beverly
About Fluid-Screen
Fluid-Screen microchip technology provides information about bacteria present in fluid samples in minutes instead of days. They help their partners, the pharmaceutical companies, accelerate the development and manufacturing of new therapeutics. Fluid-Screen provides real-time detection and identification of bacterial contamination in a variety of industries, including biotherapeutics manufacturing, healthcare, and water quality monitoring. By eliminating the time delays associated with traditional methods, the Fluid-Screen platform enables responsive, proactive decision-making when product, patient, and customer safety is jeopardized.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.3M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2022)
- Website: fluidscreen.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Diagnostics, Medical, Nanotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/fluid-screen-73221 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.